Not a member? Register today to access  TEACH-HUB content

Research Program

Table of Contents

A long road lessons learnt from two decades of cannabis driving research. Prof Jan Ramaekers.

Back to Contents

A placebo-controlled RCT of THC and CBD in Tourette Syndrome. Dr Philip Mosley

Back to Contents

Advances in cannabis plant research at AgriBio. Monika Doblin

Back to Contents

Advancing the science of plant cannabinoids in humans. Marcel Bonn-Miller.

Back to Contents

Anti-seizure, pro-sleep and entourage effects of plant cannabinoids in pre-clinical models. Prof Jonathon Arnold.

Back to Contents

Cannabidiol in preclinical in vivo models of neurodegenerative disorders. Prof Tim Karl.

Back to Contents

Cannabinoid clinical trials in Australia what we have found and where we are going next. Prof Iain McGregor.

Back to Contents

Cannabis and pain human studies on CBD, THC and opioid sparing effects. Prof Ziva Cooper.

Back to Contents

Clinical trials of cannabinoids in insomnia and neuropathic pain patients. Anastasia Suraev.

Back to Contents

Conversations about Cannabis The Supply Process in Australia. Joanna Harnett.

Back to Contents

Decreased CSF-1 secretion by cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression. A/Prof Dedi (David) Meiri.

Back to Contents

Effects of Cannabis and its Constituents on Driving Performance. Danielle McCartney.

Back to Contents

Effects of medical cannabis on driving performance. Thomas Arkell.

Back to Contents

Introducing the MINI trial Cannabis in the management of advanced paediatric cancer. Alison Bowers.

Back to Contents

Investigating cannabinoid production in trichomes. Matthew Nolan.

Back to Contents

Novel molecular actions of the cannabinoids and developments as antibacterial and anti-anxiety agents in preclinical models. Elizabeth Cairns.

Back to Contents

Paving the way Conducting Phase 1 trials on minor cannabinoids and the interactions of individual cannabis constituents. Ryan Vandrey

Back to Contents

Structural determinants of cannabinoid receptor action. Prof Michelle Glass.

Back to Contents

Studies assessing the neuroprotective effects of cannabis constituents in vitro. Dr Scott Smid.

Back to Contents

Synthesis of phytocannabinoids and their structural analogues. Adam Ametovski.

Back to Contents

The Cannabis as Medicine Survey (CAMS) trends in medicinal cannabis use in Australia. Llewellyn Mills.

Back to Contents

Who wants a longer healthspan Anti-ageing effects of cannabidiol in nematodes. Jane Wang.

Back to Contents